Advancing AAV gene therapy development for the treatment of neurodegenerative diseases

Watch the video or view the poster to find out: Benefits of using AAV for the treatment of neurodegenerative diseases Biodistribution of AAV serotypes in mouse models Comparisons of titer and immunogenicity for AAV6 and AAV9 serotypes for different delivery methods to the CNS

Please enter your email to access content Read now